BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 15158802)

  • 1. Antitumor agents. Part 227: Studies on novel 4'-O-demethyl-epipodophyllotoxins as antitumor agents targeting topoisomerase II.
    Xiao Z; Bastow KF; Vance JR; Lee KH
    Bioorg Med Chem; 2004 Jun; 12(12):3339-44. PubMed ID: 15158802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives.
    Xiao Z; Bastow KF; Vance JR; Sidwell RS; Wang HK; Chen MS; Shi Q; Lee KH
    J Med Chem; 2004 Oct; 47(21):5140-8. PubMed ID: 15456257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel carbamate derivatives of 4-beta-amino-4'-O-demethyl-4-desoxypodophyllotoxin as inhibitors of topoisomerase II: synthesis and biological evaluation.
    Duca M; Arimondo PB; Léonce S; Pierré A; Pfeiffer B; Monneret C; Dauzonne D
    Org Biomol Chem; 2005 Mar; 3(6):1074-80. PubMed ID: 15750651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor agents. Part 235: Novel 4'-ester etoposide analogues as potent DNA topoisomerase II inhibitors with improved therapeutic potential.
    Xiao Z; Vance JR; Bastow KF; Brossi A; Wang HK; Lee KH
    Bioorg Med Chem; 2004 Jun; 12(12):3363-9. PubMed ID: 15158805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin.
    Guianvarc'h D; Duca M; Boukarim C; Kraus-Berthier L; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C; Dauzonne D
    J Med Chem; 2004 Apr; 47(9):2365-74. PubMed ID: 15084135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
    Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
    Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor agents. Part 232: Synthesis of cyclosulfite podophyllotoxin analogues as novel prototype antitumor agents.
    Xiao Z; Han S; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1581-4. PubMed ID: 15006408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor agents. 164. Podophenazine, 2'',3''-dichloropodophenazine, benzopodophenazine, and their 4 beta-p-nitroaniline derivatives as novel DNA topoisomerase II inhibitors.
    Cho SJ; Kashiwada Y; Bastow KF; Cheng YC; Lee KH
    J Med Chem; 1996 Mar; 39(7):1396-402. PubMed ID: 8691469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
    Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
    J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of new 4beta-anilino- and 4beta-imido-substituted podophyllotoxin congeners.
    Kamal A; Gayatri NL; Reddy DR; Mohan Reddy PS; Arifuddin M; Dastidar SG; Kondapi AK; Rajkumar M
    Bioorg Med Chem; 2005 Nov; 13(22):6218-25. PubMed ID: 16061385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, biological evaluation and QSAR studies of novel bisepipodophyllotoxins as cytotoxic agents.
    Kamal A; Laxman E; Khanna GB; Reddy PS; Rehana T; Arifuddin M; Neelima K; Kondapi AK; Dastidar SG
    Bioorg Med Chem; 2004 Aug; 12(15):4197-209. PubMed ID: 15246096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of aroylthiourea derivatives of 4-β-amino-4'-O-demethyl-4-desoxypodophyllotoxin as novel topoisomerase II inhibitors.
    Zhao Y; Ge CW; Wu ZH; Wang CN; Fang JH; Zhu L
    Eur J Med Chem; 2011 Mar; 46(3):901-6. PubMed ID: 21277655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 4β-carbamoyl epipodophyllotoxins as potential antitumour agents.
    Kamal A; Kumar BA; Suresh P; Juvekar A; Zingde S
    Bioorg Med Chem; 2011 May; 19(9):2975-9. PubMed ID: 21489802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
    Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
    Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxic activity of novel derivatives of 4'-demethylepipodophyllotoxin.
    Chen SW; Tian X; Tu YQ
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5063-6. PubMed ID: 15380199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors.
    Han S; Xiao Z; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological study of a new series of 4'-demethylepipodophyllotoxin derivatives.
    Duca M; Guianvarc'h D; Meresse P; Bertounesque E; Dauzonne D; Kraus-Berthier L; Thirot S; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C
    J Med Chem; 2005 Jan; 48(2):593-603. PubMed ID: 15658872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II.
    Brel V; Annereau JP; Vispé S; Kruczynski A; Bailly C; Guilbaud N
    Biochem Pharmacol; 2011 Dec; 82(12):1843-52. PubMed ID: 21924246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 4 beta-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents.
    Hu C; Xu D; Du W; Qian S; Wang L; Lou J; He Q; Yang B; Hu Y
    Mol Biosyst; 2010 Feb; 6(2):410-20. PubMed ID: 20094661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
    Barret JM; Kruczynski A; Vispé S; Annereau JP; Brel V; Guminski Y; Delcros JG; Lansiaux A; Guilbaud N; Imbert T; Bailly C
    Cancer Res; 2008 Dec; 68(23):9845-53. PubMed ID: 19047165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.